A High Serum Cortisol/DHEA-S Ratio Is a Risk Factor for Sarcopenia in Elderly Diabetic Patients.

DHEA-S cortisol sarcopenia type 2 diabetes

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Apr 2019
Historique:
received: 22 08 2018
accepted: 27 02 2019
entrez: 10 4 2019
pubmed: 10 4 2019
medline: 10 4 2019
Statut: epublish

Résumé

Elderly patients with type 2 diabetes mellitus (T2DM) have a high prevalence of frailty and/or sarcopenia. Sarcopenia is thought to be related to discordant secretions of the adrenal hormones cortisol and dehydroepiandrosterone (DHEA), as well as the sulfate ester of DHEA (DHEA-S). The current study sought to evaluate the risk factors for sarcopenia in elderly patients with T2DM. We enrolled 108 consecutive elderly patients aged ≥65 years with T2DM (mean age, 76.2 ± 7.3 years; 43.5% males). Sarcopenia was assessed and diagnosed based on the Asian version of the diagnostic criteria regarding muscular strength, physical function, and muscle mass. We assessed various physical parameters, blood tests, and atherosclerosis markers and statistically determined the risk factors for sarcopenia. Multiple regression analysis showed that the independent risk factors for sarcopenia were a serum cortisol/DHEA-S ratio ≥0.2, diastolic blood pressure <70 mm Hg, Hb concentration <13 g/dL, and an ankle brachial index <1.0. The strongest risk factor for sarcopenia was a serum cortisol/DHEA-S ratio ≥0.2. An increase in the serum cortisol/DHEA-S ratio reflected higher cortisol values and lower DHEA-S values in patients with sarcopenia compared with those in nonsarcopenic patients. The concentrations of cortisol and DHEA-S, as well as the cortisol/DHEA-S ratio, changed in accordance with the severity of sarcopenia. A relative increase in cortisol may reflect the presence of stress and stimulate muscle catabolism, whereas a relative decrease in DHEA-S may cause a decrease in the anabolic action of DHEA on muscle; the combination of these factors may lead to sarcopenia.

Identifiants

pubmed: 30963138
doi: 10.1210/js.2018-00271
pii: js_201800271
pmc: PMC6446890
doi:

Types de publication

Journal Article

Langues

eng

Pagination

801-813

Références

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4279-84
pubmed: 10760294
Exp Gerontol. 2000 Dec;35(9-10):1239-50
pubmed: 11113605
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Eur J Endocrinol. 2001 Apr;144(4):319-29
pubmed: 11275940
Brain Res Brain Res Rev. 2001 Nov;37(1-3):294-300
pubmed: 11744094
Eur J Endocrinol. 2002 Mar;146(3):375-80
pubmed: 11888844
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Mech Ageing Dev. 2002 Apr 30;123(8):1101-6
pubmed: 12044959
Science. 2002 Aug 2;297(5582):811
pubmed: 12161648
J Gerontol A Biol Sci Med Sci. 2004 May;59(5):466-72
pubmed: 15123757
J Gerontol A Biol Sci Med Sci. 2004 Dec;59(12):1310-7
pubmed: 15699531
Aging Cell. 2005 Dec;4(6):319-24
pubmed: 16300484
J Clin Endocrinol Metab. 2006 Aug;91(8):2986-93
pubmed: 16735495
Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1003-8
pubmed: 16787962
J Clin Endocrinol Metab. 2006 Oct;91(10):3988-91
pubmed: 16804050
Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E577-84
pubmed: 17018772
Ann N Y Acad Sci. 2007 Oct;1114:434-55
pubmed: 17986602
J Endocrinol. 2008 Apr;197(1):1-10
pubmed: 18372227
J Am Geriatr Soc. 2008 Jun;56(6):994-8
pubmed: 18422949
Diabetes Res Clin Pract. 2008 Dec;82(3):378-82
pubmed: 18930561
Age Ageing. 2009 Jul;38(4):401-6
pubmed: 19276095
J Am Geriatr Soc. 2009 May;57(5):840-7
pubmed: 19484839
Eur J Endocrinol. 2010 May;162(5):919-23
pubmed: 20164211
Acta Paediatr. 2010 Jul;99(7):1065-72
pubmed: 20178516
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Eur J Endocrinol. 2010 Aug;163(2):285-92
pubmed: 20498139
J Am Geriatr Soc. 2010 Sep;58(9):1707-14
pubmed: 20863330
J Med Phys. 2007 Oct;32(4):161-8
pubmed: 21224926
Cell Metab. 2011 Feb 2;13(2):170-82
pubmed: 21284984
Horm Metab Res. 2011 Sep;43(10):702-7
pubmed: 21932174
Age (Dordr). 2013 Jun;35(3):963-71
pubmed: 22388931
J Am Geriatr Soc. 2012 Sep;60(9):1701-7
pubmed: 22882211
J Gerontol A Biol Sci Med Sci. 2014 Apr;69(4):438-46
pubmed: 24085400
Endocrinol Metab (Seoul). 2013 Jun;28(2):86-9
pubmed: 24396659
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
J Steroid Biochem Mol Biol. 2015 Jan;145:200-5
pubmed: 24704257
Lancet Diabetes Endocrinol. 2014 Oct;2(10):819-29
pubmed: 24731660
J Diabetes Investig. 2010 Oct 19;1(5):212-28
pubmed: 24843435
Compr Physiol. 2014 Oct;4(4):1495-510
pubmed: 25428852
Curr Hypertens Rep. 2015 Jul;17(7):55
pubmed: 26068656
Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):196-201
pubmed: 26523513
J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1223-9
pubmed: 26933160
J Diabetes Investig. 2018 Mar;9(2):419-425
pubmed: 28556518
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2798-2806
pubmed: 28609827
Arch Phys Med Rehabil. 2018 Apr;99(4):623-628
pubmed: 29138051
Endocr J. 2018 Jan 30;65(1):1-11
pubmed: 29238004
Gerontology. 1986;32(1):43-51
pubmed: 3005134
J Clin Endocrinol Metab. 1984 Sep;59(3):551-5
pubmed: 6235241
J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):165-74
pubmed: 7626449
J Clin Endocrinol Metab. 1994 Nov;79(5):1273-6
pubmed: 7962319
J Clin Epidemiol. 1993 Oct;46(10):1129-40
pubmed: 8410098
Obes Res. 1995 Dec;3 Suppl 5:639S-643S
pubmed: 8653543
Endocr J. 1996 Feb;43(1):119-23
pubmed: 8732462
Horm Metab Res. 1995 Nov;27(11):491-4
pubmed: 8770624
Atherosclerosis. 1996 Sep 27;126(1):143-54
pubmed: 8879442
Science. 1997 Oct 17;278(5337):419-24
pubmed: 9334293
J Am Geriatr Soc. 1998 Mar;46(3):263-73
pubmed: 9514370
Neurology. 1998 Aug;51(2):586-9
pubmed: 9710041
Am J Geriatr Psychiatry. 1998 Fall;6(4):277-84
pubmed: 9793575

Auteurs

Ikumi Yanagita (I)

Muta Hospital, Fukuoka, Japan.
Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Yuya Fujihara (Y)

Muta Hospital, Fukuoka, Japan.

Yuichi Kitajima (Y)

Muta Hospital, Fukuoka, Japan.

Misuzu Tajima (M)

Muta Hospital, Fukuoka, Japan.

Masanao Honda (M)

Muta Hospital, Fukuoka, Japan.

Tomoko Kawajiri (T)

Muta Hospital, Fukuoka, Japan.

Terumi Eda (T)

Muta Hospital, Fukuoka, Japan.

Kazue Yonemura (K)

Muta Hospital, Fukuoka, Japan.

Noriko Yamaguchi (N)

Muta Hospital, Fukuoka, Japan.

Hideko Asakawa (H)

Muta Hospital, Fukuoka, Japan.

Yukiko Nei (Y)

Muta Hospital, Fukuoka, Japan.

Yumi Kayashima (Y)

Muta Hospital, Fukuoka, Japan.

Mihoko Yoshimoto (M)

Muta Hospital, Fukuoka, Japan.

Mayumi Harada (M)

Muta Hospital, Fukuoka, Japan.

Yuhei Araki (Y)

Muta Hospital, Fukuoka, Japan.

Shoji Yoshimoto (S)

Muta Hospital, Fukuoka, Japan.

Eiji Aida (E)

Muta Hospital, Fukuoka, Japan.

Toshihiko Yanase (T)

Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Hajime Nawata (H)

Muta Hospital, Fukuoka, Japan.

Kazuo Muta (K)

Muta Hospital, Fukuoka, Japan.

Classifications MeSH